Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
autologous hematopoietic stem cells
- Development stage
- Phase 3
- Lead developer
- Ruijin Hospital
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
Autologous hematopoietic stem cells (HSCs) are being evaluated by Ruijin Hospital as a therapeutic "boost" to treat severe or prolonged myelosuppression in patients with B-cell non-Hodgkin lymphoma (B-NHL) who have undergone chimeric antigen receptor T-cell (CAR-T) therapy. Myelosuppression, characterized by a significant decrease in blood cell production, is a common high-risk immunohematologic toxicity associated with CAR-T treatments. This intervention involves the infusion of a previously collected and cryopreserved reserve of the patient's own HSCs. Once infused, these cells are intended to engraft in the bone marrow and restore hematopoiesis, thereby accelerating the recovery of red blood cells, white blood cells, and platelets in patients who do not respond to standard supportive care.
- Other names
- autologous hematopoietic stem cell booststem cell boostSCB
Beyond the preview
Go deeper on autologous hematopoietic stem cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on autologous hematopoietic stem cells.